| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/25/2013 | CN102260335B Pichia pastoris wall protein Gcw3, and surface display system and construction method thereof |
| 09/25/2013 | CN102260329B Pichia pastoris wall protein Gcw45, and surface display system and construction method thereof |
| 09/25/2013 | CN102260328B Antigen proteins of Mycobacterium tuberculosis and application thereof |
| 09/25/2013 | CN102174096B Ciona intestinalis polypeptide and preparation method thereof |
| 09/25/2013 | CN102012432B Colloidal gold immunochromatographic test paper based on recombinant UL51 protein as well as preparation method and application thereof |
| 09/25/2013 | CN102004150B Recombinant UL51 protein-based method for detecting duck plague virus antibody |
| 09/25/2013 | CN101993480B Broccoli leaf protein and preparation method thereof |
| 09/25/2013 | CN101982777B Duck plague virus antigen capturing ELISA method based on anti-recombination UL51 albumen antibody |
| 09/25/2013 | CN101974085B Method for extracting high-anticoagulation-activity hirudin from natural leeches |
| 09/25/2013 | CN101915848B Application of RBD protein in preparation of auxiliary diagnostic agent for SARS patients |
| 09/25/2013 | CN101475636B Human interferon-like protein and use thereof |
| 09/25/2013 | CN101400785B Method for production of t cell population |
| 09/25/2013 | CN101374536B Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 09/24/2013 | US8541664 Soybean cultivar 15115139 |
| 09/24/2013 | US8541655 Transgenic plants expressing modified Cry3A |
| 09/24/2013 | US8541654 Use of recombinant polypeptides from the genus Lupinus as antimicrobial or insecticidal on plants |
| 09/24/2013 | US8541649 Brassinosteroid regulated kinases (BRKs) that mediate brassinosteroid signal transduction and uses thereof |
| 09/24/2013 | US8541551 Immunogen and antivenom against violin spider venom |
| 09/24/2013 | US8541550 Methods and compositions for delivering polynucleotides |
| 09/24/2013 | US8541545 Stabilized melanocortin ligands |
| 09/24/2013 | US8541376 Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 09/24/2013 | US8541371 Treatment of conditions related to cecal ligation shock |
| 09/24/2013 | US8541366 Synthetic AXMI-004 delta-endotoxin genes and methods for their use |
| 09/24/2013 | US8541236 Oxidation resistant mutant apoA-I polypeptide having a combination of: a conservative amino acid substitution at residue Tyr192; and at least one conservative amino acid substitution at residue Met86, Met112, or Met148; promoting cholesterol efflux; atherosclerosis |
| 09/24/2013 | US8541230 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 09/24/2013 | US8541219 High fidelity reverse transcriptases and the uses thereof |
| 09/24/2013 | US8541203 Activatable binding polypeptides and methods of identification and use thereof |
| 09/24/2013 | US8541198 Method for determination and quantification of radiation or genotoxin exposure |
| 09/24/2013 | US8541177 Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction |
| 09/24/2013 | US8541046 Process for the preparation of a canola protein isolate |
| 09/24/2013 | US8541004 Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 09/24/2013 | US8541003 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 09/24/2013 | US8541002 Vaccine for treatment and prevention of herpes simplex virus infection |
| 09/24/2013 | US8541000 Variant of mite allergen and uses thereof |
| 09/24/2013 | US8540999 Allergenic proteins and peptides from Japanese cedar pollen |
| 09/24/2013 | US8540997 Complement receptor 1 and 2 fusion proteins |
| 09/24/2013 | US8540979 Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein |
| 09/24/2013 | US8540977 IL-11 muteins |
| 09/24/2013 | CA2770851C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/24/2013 | CA2699894C Cholesterol derivatives of inhibitors of viral fusion |
| 09/24/2013 | CA2693956C Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 09/24/2013 | CA2640076C Genes for enhancing nitrogen utilization efficiency in crop plants |
| 09/24/2013 | CA2587643C Method for designing polypeptides for the nanofabrication of thin films, coatings, and microcapsules by electrostatic layer-by-layer self assembly |
| 09/24/2013 | CA2522359C Pathotropic retroviral vector used to deliver diagnostic or therapeutic compositions |
| 09/24/2013 | CA2486583C Marker molecules associated with lung tumors |
| 09/24/2013 | CA2477569C Selective binding of pathological forms of prion proteins using polyionic polymers |
| 09/24/2013 | CA2476410C Methods to increase or decrease bone density |
| 09/24/2013 | CA2471817C Labeling targeting agents with gallium-68 and gallium-67 |
| 09/24/2013 | CA2448427C Molecules and methods for inhibiting shedding of kim-1 |
| 09/24/2013 | CA2425669C Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/24/2013 | CA2417970C 2,5-dkg permeases |
| 09/24/2013 | CA2405557C Albumin fusion proteins |
| 09/24/2013 | CA2318857C Use of heregulin as an epithelial cell growth factor |
| 09/24/2013 | CA2312478C G-protein coupled receptors and uses therefor |
| 09/20/2013 | CA2771954A1 Pneumonia biomarkers |
| 09/19/2013 | WO2013138795A1 Cell penetrating compositions for delivery of intracellular antibodies and antibody-like moieties and methods of use |
| 09/19/2013 | WO2013138400A1 Multispecific antigen-binding molecules and uses thereof |
| 09/19/2013 | WO2013138363A2 Genetic reduction of male fertility in plants |
| 09/19/2013 | WO2013138358A1 Genetic reduction of male fertility in plants |
| 09/19/2013 | WO2013138354A1 Genetic reduction of male fertility in plants |
| 09/19/2013 | WO2013138289A2 Genetic reduction of male fertility in plants |
| 09/19/2013 | WO2013137920A1 Engineered conformationally-stabilized proteins |
| 09/19/2013 | WO2013137505A1 Novel trpv1 inhibitory peptide and anti-aging or anti-wrinkle composition for skin comprising same |
| 09/19/2013 | WO2013137490A1 Polypeptide involved in morphogenesis and/or environmental stress resistance of plant |
| 09/19/2013 | WO2013136274A1 Myb55 promoter and use thereof |
| 09/19/2013 | WO2013136189A2 Methods and materials for treatment of pompe's disease |
| 09/19/2013 | WO2013136180A2 Chimeric proteins for treatment of diseases |
| 09/19/2013 | WO2013136078A1 Therapeutic use of p75ntr neurotrophin binding protein |
| 09/19/2013 | WO2013135896A1 Albumin variants |
| 09/19/2013 | WO2013135748A1 Polypeptides binding to dll4 and uses thereof |
| 09/19/2013 | WO2013135747A1 Polypeptides binding to dll4 and uses thereof |
| 09/19/2013 | WO2013135732A1 Rasamsonia transformants |
| 09/19/2013 | WO2013135684A1 Improved process for production of fibrinogen and fibrinogen produced thereby |
| 09/19/2013 | WO2013135103A1 Polypeptide carrying melittin, nanoparticle carrying melittin and use thereof |
| 09/19/2013 | WO2013134881A1 Generating targeted sequence diversity in fusion proteins |
| 09/19/2013 | WO2013134880A1 Generating targeted sequence diversity in proteins |
| 09/19/2013 | WO2013042120A3 Synthetic ubiquitins and use thereof in drug screening assays |
| 09/19/2013 | WO2012088159A3 Endoglucanase variants |
| 09/19/2013 | US20130247249 Gene controlling shell phenotype in palm |
| 09/19/2013 | US20130247248 Transcription factors in plants related to levels of nitrate and methods of using the same |
| 09/19/2013 | US20130247233 G protein coupled receptors and uses thereof |
| 09/19/2013 | US20130247232 Colon and pancreas cancer peptidomimetics |
| 09/19/2013 | US20130245241 Risperidone Immunoassay |
| 09/19/2013 | US20130245238 Fibronectin Binding Domains with Reduced Immunogenicity |
| 09/19/2013 | US20130245234 Vmp-like sequences of pathogenic borrelia |
| 09/19/2013 | US20130245227 Methods of activating clostridial toxins |
| 09/19/2013 | US20130245226 Antibodies To Non-Functional P2X7 Receptor |
| 09/19/2013 | US20130245103 Modified polynucleotides for the production of factor ix |
| 09/19/2013 | US20130245100 Polynucleotide for use in treatment of influenza a virus induced diseases, encoding modified mx protein, said modified mx protein, and a transgenic animal expressing gene encoding modified mx protein |
| 09/19/2013 | US20130245037 Stabilization of Hypoxia Inducible Factor (HIF) Alpha |
| 09/19/2013 | US20130244955 Binding proteins for hepcidin |
| 09/19/2013 | US20130244940 Designed repeat proteins binding to serum albumin |
| 09/19/2013 | US20130244939 Novel peptides that bind to the erythropoietin receptor |
| 09/19/2013 | US20130244938 Relaxin Analogs |
| 09/19/2013 | US20130244933 Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion |
| 09/19/2013 | US20130244931 Novel GLP-1 Derivatives |
| 09/19/2013 | US20130244928 Antimicrobial peptides and derived metapeptides |
| 09/19/2013 | US20130244927 Polynucleotides encoding signal peptide-containing molecules |
| 09/19/2013 | US20130244924 Peptide compounds to regulate the complement system |
| 09/19/2013 | US20130244330 Novel Substitution Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System |